尋常性疣贅の世界市場レポート 2025年

尋常性疣贅市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.8％で28億3,000万米ドルに成長します。予測期間中の成長は、高齢者人口の増加、ウイルス感染症の流行、先進皮膚科治療の採用増加、個別化治療に対する需要の高まり、在宅ケアソリューションに対する消費者の嗜好の高まりなどの要因によるものと考えられます。この期間の主な動向としては、皮膚科治療の進歩、ヘルスケア・インフラの拡大、イボ取り治療における技術革新、利用可能な治療オプションの認知度向上、低侵襲治療へのシフトなどが挙げられます。

ウイルス感染症の増加は、今後数年間の尋常性疣贅市場の成長を促進すると予想されます。ウイルス感染症は、体内に侵入、増殖、拡散するウイルスによって引き起こされる疾患で、細胞や免疫反応に影響を与えます。このような感染症の蔓延は、世界化、気候変動、都市化、森林伐採、免疫力の低下などの要因に影響されています。尋常性疣贅治療は、イボ形成の原因となるヒトパピローマウイルス（HPV）を標的とし、ウイルスの感染を抑え、不快感を和らげ、治癒を促進することで、ウイルス感染患者に重要なサポートを提供します。これにより、二次感染や瘢痕化などの合併症を予防し、患者の生活の質を向上させることができます。例えば、2024年、米国疾病予防管理センターは、2022年にPCRで確認された水痘症例の割合が62％増加し、過去5年間で29％から47％に増加したと報告しました。さらに、2023年1月、全米感染症財団は、米国では年間推定1,400万件のHPV感染症例が新たに発生していると指摘しました。その結果、ウイルス感染症の罹患率の上昇が尋常性疣贅市場の成長を促進しています。

尋常性疣贅市場の主要企業は、効果的で利用しやすいソリューションに対する需要の高まりに対応するため、皮膚科治療などの革新的な治療の進展に注力しています。これらの治療は、患者の予後を改善し、皮膚科分野での市場プレゼンスを拡大することを目的としています。皮膚科治療とは、感染症、炎症、障害を含む皮膚疾患の治療を指します。例えば、2024年5月、米国の製薬会社Verrica Pharmaceuticalsは、日本の製薬会社である鳥居薬品株式会社とライセンス契約を締結しました。この提携は、世界の治療薬開発に資金を提供することを目的としています。この提携は、尋常性疣贅の治療薬であるYCANTHの国際共同第3相臨床試験に資金を提供するためのものです。本契約は、YCANTHの後期開発を支援し、より広範な世界市場への参入を支援するものです。鳥居薬品は、両社の皮膚科領域におけるポートフォリオを強化し、国際的なプレゼンスを拡大するため、本試験を支援する資金を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界尋常性疣贅PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の尋常性疣贅市場：成長率分析
• 世界の尋常性疣贅市場の実績：規模と成長, 2019-2024
• 世界の尋常性疣贅市場の予測：規模と成長, 2024-2029, 2034F
• 世界尋常性疣贅総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の尋常性疣贅市場治療方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凍結療法
• レーザー治療
• 電気外科手術
• 外用薬
• 世界の尋常性疣贅市場患者の人口統計別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供たち
• 大人
• お年寄り
• 世界の尋常性疣贅市場病気のステージ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 初期
• 中等度
• 重症期
• 世界の尋常性疣贅市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 皮膚科クリニック
• ホームケア
• 世界の尋常性疣贅市場凍結療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 液体窒素療法
• 二酸化炭素療法
• 世界の尋常性疣贅市場、レーザー治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パルス色素レーザー療法
• 二酸化炭素（CO2）レーザー療法
• 世界の尋常性疣贅市場電気外科手術の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 掻爬術と電気外科手術による除去
• 高周波電気外科アブレーション
• 世界の尋常性疣贅市場外用薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サリチル酸ベースの療法
• 免疫療法ベースの外用薬
• レチノイドベースの療法

第7章 地域別・国別分析

• 世界の尋常性疣贅市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の尋常性疣贅市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 尋常性疣贅市場：競合情勢
• 尋常性疣贅市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • Perrigo Company plc Overview, Products and Services, Strategy and Financial Analysis
  • Holland & Barrett International Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Prestige Consumer Healthcare Inc.
• Maruho Co. Ltd.
• Novan Inc.
• X4 Pharmaceuticals Inc.
• Aclaris Therapeutics Inc.
• Verrica Pharmaceuticals Inc.
• RXi Pharmaceuticals Corporation
• Scholl's Wellness Company
• Nielsen BioSciences Inc.
• Cassiopea S.p.A.
• Orgenesis Inc.
• KinoPharma Inc.
• Naturasil
• Veradermics Inc.
• KinoPharma Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 尋常性疣贅市場2029：新たな機会を提供する国
• 尋常性疣贅市場2029：新たな機会を提供するセグメント
• 尋常性疣贅市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, acting as a defense mechanism for the body in response to the viral infection.

The main treatment options for common warts include cryotherapy, laser treatment, electrosurgery, and topical medications. Cryotherapy is a treatment that uses extreme cold, usually liquid nitrogen, to freeze and destroy abnormal tissue. These treatments are provided across various patient demographics, including children, adults, and the elderly. Treatment approaches vary depending on the stage of the condition, with options tailored for the initial, moderate, or severe stages. These treatments are administered in various settings, such as hospitals, dermatology clinics, and home care.

The common warts market research report is one of a series of new reports from The Business Research Company that provides common warts market statistics, including the common warts industry global market size, regional shares, competitors with the common warts market share, detailed common warts market segments, market trends, and opportunities, and any further data you may need to thrive in the common warts industry. These common warts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The common warts market size has grown strongly in recent years. It will grow from $2.13 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to factors such as increased awareness of skin health, a rising incidence of warts, growing demand for non-invasive procedures, the increasing use of cryotherapy, and the expansion of dermatology clinics.

The common warts market size is expected to see strong growth in the next few years. It will grow to $2.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to factors such as the rising geriatric population, the growing prevalence of viral infections, increased adoption of advanced dermatological therapies, a growing demand for personalized treatments, and a higher consumer preference for homecare solutions. Key trends during this period include advancements in dermatological treatments, expanding healthcare infrastructure, technological innovations in wart removal treatments, greater awareness of available treatment options, and a shift towards minimally invasive treatments.

The rising occurrence of viral infections is expected to drive the growth of the common warts market in the coming years. Viral infections are diseases caused by viruses that enter, multiply, and spread within the body, affecting cells and immune responses. The growing prevalence of these infections is influenced by factors such as globalization, climate change, urbanization, deforestation, and weakened immune systems. Common warts treatments target the human papillomavirus (HPV) responsible for wart formation, providing vital support for viral infection patients by reducing virus transmission, easing discomfort, and promoting healing. This helps prevent complications such as secondary infections or scarring while improving the patient's quality of life. For example, in 2024, the Centers for Disease Control and Prevention reported that, in 2022, the proportion of PCR-confirmed varicella cases rose by 62%, increasing from 29% to 47% over the past five years. Additionally, in January 2023, the National Foundation for Infectious Diseases noted that there are an estimated 14 million new cases of HPV infection annually in the United States. As a result, the rising incidence of viral infections is driving growth in the common warts market.

Key players in the common warts market are focusing on advancing innovative treatments, such as dermatological therapies, to address the growing demand for effective and accessible solutions. These treatments aim to improve patient outcomes and expand market presence in the dermatology sector. Dermatological therapies refer to treatments for skin conditions, including infections, inflammations, and disorders. For instance, in May 2024, Verrica Pharmaceuticals, a U.S.-based pharmaceutical company, entered into a licensing agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment for common warts. The agreement supports the late-stage development of YCANTH, helping it reach a broader global market. Torii Pharmaceuticals will contribute financial resources to support the study, which will enhance both companies' dermatology portfolios and expand their international presence.

In June 2023, Vial, a U.S.-based clinical trial management organization, partnered with Nielsen BioSciences to conduct a Phase 3 clinical trial for CANDIN. This collaboration is aimed at further developing CANDIN as a potential treatment for common warts by evaluating its safety and efficacy. Nielsen BioSciences, a U.S.-based biotechnology company specializing in immune-based therapies, is helping advance CANDIN as a promising treatment option.

Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl's Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in common warts report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the common warts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The common warts market consists of revenues earned by entities by providing services such as telemedicine consultations, therapy services, and surgical excision. The market value includes the value of related goods sold by the service provider or included within the service offering. The common warts market also includes sales of over-the-counter (OTC) treatments, prescription medications, and medical devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Common Warts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on common warts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for common warts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The common warts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Method: Cryotherapy; Laser Treatment; Electrosurgery; Topical Medications
• 2) By Patient Demographics: Children; Adults; Elderly
• 3) By Disease Stage: Initial Stage; Moderate Stage; Severe Stage
• 4) By End User: Hospitals; Dermatology Clinics; Home Care
• Subsegments:
• 1) By Cryotherapy: Liquid Nitrogen Therapy; Carbon Dioxide Therapy
• 2) By Laser Treatment: Pulsed-Dye Laser Therapy; Carbon Dioxide (CO2) Laser Therapy
• 3) By Electrosurgery: Curettage And Electrosurgical Removal; High-Frequency Electrosurgical Ablation
• 4) By Topical Medications: Salicylic Acid-Based Therapy; Immunotherapy-Based Topicals; Retinoid-Based Therapy
• Companies Mentioned: AbbVie Inc.; GlaxoSmithKline plc; Sun Pharmaceutical Industries Limited; Perrigo Company plc; Holland & Barrett International Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Common Warts Market Characteristics

3. Common Warts Market Trends And Strategies

4. Common Warts Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Common Warts Growth Analysis And Strategic Analysis Framework

• 5.1. Global Common Warts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Common Warts Market Growth Rate Analysis
• 5.4. Global Common Warts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Common Warts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Common Warts Total Addressable Market (TAM)

6. Common Warts Market Segmentation

• 6.1. Global Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryotherapy
• Laser Treatment
• Electrosurgery
• Topical Medications
• 6.2. Global Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children
• Adults
• Elderly
• 6.3. Global Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Initial Stage
• Moderate Stage
• Severe Stage
• 6.4. Global Common Warts Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Dermatology Clinics
• Home Care
• 6.5. Global Common Warts Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Nitrogen Therapy
• Carbon Dioxide Therapy
• 6.6. Global Common Warts Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulsed-Dye Laser Therapy
• Carbon Dioxide (CO2) Laser Therapy
• 6.7. Global Common Warts Market, Sub-Segmentation Of Electrosurgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Curettage And Electrosurgical Removal
• High-Frequency Electrosurgical Ablation
• 6.8. Global Common Warts Market, Sub-Segmentation Of Topical Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Salicylic Acid-Based Therapy
• Immunotherapy-Based Topicals
• Retinoid-Based Therapy

7. Common Warts Market Regional And Country Analysis

• 7.1. Global Common Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Common Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Common Warts Market

• 8.1. Asia-Pacific Common Warts Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Common Warts Market

• 9.1. China Common Warts Market Overview
• 9.2. China Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Common Warts Market

• 10.1. India Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Common Warts Market

• 11.1. Japan Common Warts Market Overview
• 11.2. Japan Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Common Warts Market

• 12.1. Australia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Common Warts Market

• 13.1. Indonesia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Common Warts Market

• 14.1. South Korea Common Warts Market Overview
• 14.2. South Korea Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Common Warts Market

• 15.1. Western Europe Common Warts Market Overview
• 15.2. Western Europe Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Common Warts Market

• 16.1. UK Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Common Warts Market

• 17.1. Germany Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Common Warts Market

• 18.1. France Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Common Warts Market

• 19.1. Italy Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Common Warts Market

• 20.1. Spain Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Common Warts Market

• 21.1. Eastern Europe Common Warts Market Overview
• 21.2. Eastern Europe Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Common Warts Market

• 22.1. Russia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Common Warts Market

• 23.1. North America Common Warts Market Overview
• 23.2. North America Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Common Warts Market

• 24.1. USA Common Warts Market Overview
• 24.2. USA Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Common Warts Market

• 25.1. Canada Common Warts Market Overview
• 25.2. Canada Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Common Warts Market

• 26.1. South America Common Warts Market Overview
• 26.2. South America Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Common Warts Market

• 27.1. Brazil Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Common Warts Market

• 28.1. Middle East Common Warts Market Overview
• 28.2. Middle East Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Common Warts Market

• 29.1. Africa Common Warts Market Overview
• 29.2. Africa Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Common Warts Market Competitive Landscape And Company Profiles

• 30.1. Common Warts Market Competitive Landscape
• 30.2. Common Warts Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Perrigo Company plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Holland & Barrett International Limited Overview, Products and Services, Strategy and Financial Analysis

31. Common Warts Market Other Major And Innovative Companies

• 31.1. Prestige Consumer Healthcare Inc.
• 31.2. Maruho Co. Ltd.
• 31.3. Novan Inc.
• 31.4. X4 Pharmaceuticals Inc.
• 31.5. Aclaris Therapeutics Inc.
• 31.6. Verrica Pharmaceuticals Inc.
• 31.7. RXi Pharmaceuticals Corporation
• 31.8. Scholl's Wellness Company
• 31.9. Nielsen BioSciences Inc.
• 31.10. Cassiopea S.p.A.
• 31.11. Orgenesis Inc.
• 31.12. KinoPharma Inc.
• 31.13. Naturasil
• 31.14. Veradermics Inc.
• 31.15. KinoPharma Co. Ltd.

32. Global Common Warts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Common Warts Market

34. Recent Developments In The Common Warts Market

35. Common Warts Market High Potential Countries, Segments and Strategies

• 35.1 Common Warts Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Common Warts Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Common Warts Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer